Healthcare - Biotechnology - NASDAQ - US
$ 17.72
-4.06 %
$ 1.52 B
Market Cap
-3.92
P/E
Price Target
Average
22.54%
Revenue Forecast
Estimate
50.93%
EBIT
Estimate
--15.97%
Net Income
Estimate
33.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Travere Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TVTX of $21.7 , with forecasts ranging from a low of $12 to a high of $33 .
TVTX Lowest Price Target
Wall Street Target
12 USD
-32.28%
TVTX Average Price Target
Wall Street Target
21.7 USD
22.54%
TVTX Highest Price Target
Wall Street Target
33 USD
86.23%
REVENUE FORECAST
Revenue Forecast Chart TVTX
EBIT FORECAST
EBIT Forecast Chart TVTX
NET INCOME FORECAST
Net Income Chart TVTX